Visanne 2 mg Tablets contain dienogest, a fourth-generation progestogen with anti-androgenic and anti-gonadotropic properties. Primarily indicated for the treatment of endometriosis (relief of pelvic pain, dysmenorrhoea, and dyspareunia) by suppressing ovarian activity and endometrial growth while maintaining minimal impact on bone density and lipid profile. Also used off-label or in some countries as a progestogen-only contraceptive (mini-pill) with high Pearl Index reliability when taken continuously without breaks. The 28-tablet pack supports continuous daily dosing without placebo or break weeks, leading to reduced or absent menstruation in many users. Provides effective symptom control in endometriosis with once-daily convenience. Benefits • Significant reduction in endometriosis-associated pain (clinically proven in long-term studies) • Decreases menstrual bleeding – often leads to amenorrhoea (no periods) for better quality of life • Anti-androgenic effects – helpful for acne or hirsutism in some patients • No oestrogen – suitable for women with oestrogen contraindications (e.g., thrombosis risk, migraines) • Continuous regimen – no weekly breaks, simpler compliance • Well tolerated long-term with favourable safety profile on bone and metabolic parameters How to Use • Adults: 1 tablet once daily at the same time, with or without food • Start on any day of cycle (for contraception: day 1–5 for immediate protection) • Continuous use – no tablet-free interval; start next pack immediately after finishing current one • Swallow whole with water • For endometriosis: long-term use (6–24 months or more) under medical supervision • Missed tablet: take as soon as remembered (even if two at once); continue normally • Regular gynaecological check-ups recommended • Not for use in pregnancy or breastfeeding